Cargando…

Dl-3-N-Butylphthalide Promotes Angiogenesis in an Optimized Model of Transient Ischemic Attack in C57BL/6 Mice

Transient ischemic attack (TIA) has been widely regarded as a clinical entity. Even though magnetic resonance imaging (MRI) results of TIA patients are negative, potential neurovascular damage might be present, and may account for long-term cognitive impairment. Animal models that simulate human dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiahui, Li, Yanyan, Yu, Haihan, Li, Gaigai, Bai, Shuang, Chen, Shiling, Zhang, Ping, Tang, Zhouping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513739/
https://www.ncbi.nlm.nih.gov/pubmed/34658892
http://dx.doi.org/10.3389/fphar.2021.751397
_version_ 1784583263826739200
author Wang, Jiahui
Li, Yanyan
Yu, Haihan
Li, Gaigai
Bai, Shuang
Chen, Shiling
Zhang, Ping
Tang, Zhouping
author_facet Wang, Jiahui
Li, Yanyan
Yu, Haihan
Li, Gaigai
Bai, Shuang
Chen, Shiling
Zhang, Ping
Tang, Zhouping
author_sort Wang, Jiahui
collection PubMed
description Transient ischemic attack (TIA) has been widely regarded as a clinical entity. Even though magnetic resonance imaging (MRI) results of TIA patients are negative, potential neurovascular damage might be present, and may account for long-term cognitive impairment. Animal models that simulate human diseases are essential tools for in-depth study of TIA. Previous studies have clarified that Dl-3-N-butylphthalide (NBP) promotes angiogenesis after stroke. However, the effects of NBP on TIA remain unknown. This study aims to develop an optimized TIA model in C57BL/6 mice to explore the microscopic evidence of ischemic injury after TIA, and investigate the therapeutic effects of NBP on TIA. C57BL/6 mice underwent varying durations (7, 8, 9 or 10 min) of middle cerebral artery occlusion (MCAO). Cerebral artery occlusion and reperfusion were assessed by laser speckle contrast imaging. TIA and ischemic stroke were distinguished by neurological testing and MRI examination at 24 h post-operation. Neuronal apoptosis was examined by TUNEL staining. Images of submicron cerebrovascular networks were obtained via micro-optical sectioning tomography. Subsequently, the mice were randomly assigned to a sham-operated group, a vehicle-treated TIA group or an NBP-treated TIA group. Vascular density was determined by immunofluorescent staining and fluorescein isothiocyanate method, and the expression of angiogenic growth factors were detected by western blot analysis. We found that an 8-min or shorter period of ischemia induced neither permanent neurological deficits nor MRI detectable brain lesions in C57BL/6 mice, but histologically caused neuronal apoptosis and cerebral vasculature abnormalities. NBP treatment increased the number of CD31(+) microvessels and perfused microvessels after TIA. NBP also up-regulated the expression of VEGF, Ang-1 and Ang-2 and improved the cerebrovascular network. In conclusion, 8 min or shorter cerebral ischemia induced by the suture MCAO method is an appropriate TIA model in C57BL/6 mice, which conforms to the definition of human TIA, but causes microscopic neurovascular impairment. NBP treatment increased the expression of angiogenic growth factors, promoted angiogenesis and improved cerebral microvessels after TIA. Our study provides new insights on the pathogenesis and potential treatments of TIA.
format Online
Article
Text
id pubmed-8513739
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85137392021-10-14 Dl-3-N-Butylphthalide Promotes Angiogenesis in an Optimized Model of Transient Ischemic Attack in C57BL/6 Mice Wang, Jiahui Li, Yanyan Yu, Haihan Li, Gaigai Bai, Shuang Chen, Shiling Zhang, Ping Tang, Zhouping Front Pharmacol Pharmacology Transient ischemic attack (TIA) has been widely regarded as a clinical entity. Even though magnetic resonance imaging (MRI) results of TIA patients are negative, potential neurovascular damage might be present, and may account for long-term cognitive impairment. Animal models that simulate human diseases are essential tools for in-depth study of TIA. Previous studies have clarified that Dl-3-N-butylphthalide (NBP) promotes angiogenesis after stroke. However, the effects of NBP on TIA remain unknown. This study aims to develop an optimized TIA model in C57BL/6 mice to explore the microscopic evidence of ischemic injury after TIA, and investigate the therapeutic effects of NBP on TIA. C57BL/6 mice underwent varying durations (7, 8, 9 or 10 min) of middle cerebral artery occlusion (MCAO). Cerebral artery occlusion and reperfusion were assessed by laser speckle contrast imaging. TIA and ischemic stroke were distinguished by neurological testing and MRI examination at 24 h post-operation. Neuronal apoptosis was examined by TUNEL staining. Images of submicron cerebrovascular networks were obtained via micro-optical sectioning tomography. Subsequently, the mice were randomly assigned to a sham-operated group, a vehicle-treated TIA group or an NBP-treated TIA group. Vascular density was determined by immunofluorescent staining and fluorescein isothiocyanate method, and the expression of angiogenic growth factors were detected by western blot analysis. We found that an 8-min or shorter period of ischemia induced neither permanent neurological deficits nor MRI detectable brain lesions in C57BL/6 mice, but histologically caused neuronal apoptosis and cerebral vasculature abnormalities. NBP treatment increased the number of CD31(+) microvessels and perfused microvessels after TIA. NBP also up-regulated the expression of VEGF, Ang-1 and Ang-2 and improved the cerebrovascular network. In conclusion, 8 min or shorter cerebral ischemia induced by the suture MCAO method is an appropriate TIA model in C57BL/6 mice, which conforms to the definition of human TIA, but causes microscopic neurovascular impairment. NBP treatment increased the expression of angiogenic growth factors, promoted angiogenesis and improved cerebral microvessels after TIA. Our study provides new insights on the pathogenesis and potential treatments of TIA. Frontiers Media S.A. 2021-09-29 /pmc/articles/PMC8513739/ /pubmed/34658892 http://dx.doi.org/10.3389/fphar.2021.751397 Text en Copyright © 2021 Wang, Li, Yu, Li, Bai, Chen, Zhang and Tang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Jiahui
Li, Yanyan
Yu, Haihan
Li, Gaigai
Bai, Shuang
Chen, Shiling
Zhang, Ping
Tang, Zhouping
Dl-3-N-Butylphthalide Promotes Angiogenesis in an Optimized Model of Transient Ischemic Attack in C57BL/6 Mice
title Dl-3-N-Butylphthalide Promotes Angiogenesis in an Optimized Model of Transient Ischemic Attack in C57BL/6 Mice
title_full Dl-3-N-Butylphthalide Promotes Angiogenesis in an Optimized Model of Transient Ischemic Attack in C57BL/6 Mice
title_fullStr Dl-3-N-Butylphthalide Promotes Angiogenesis in an Optimized Model of Transient Ischemic Attack in C57BL/6 Mice
title_full_unstemmed Dl-3-N-Butylphthalide Promotes Angiogenesis in an Optimized Model of Transient Ischemic Attack in C57BL/6 Mice
title_short Dl-3-N-Butylphthalide Promotes Angiogenesis in an Optimized Model of Transient Ischemic Attack in C57BL/6 Mice
title_sort dl-3-n-butylphthalide promotes angiogenesis in an optimized model of transient ischemic attack in c57bl/6 mice
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513739/
https://www.ncbi.nlm.nih.gov/pubmed/34658892
http://dx.doi.org/10.3389/fphar.2021.751397
work_keys_str_mv AT wangjiahui dl3nbutylphthalidepromotesangiogenesisinanoptimizedmodeloftransientischemicattackinc57bl6mice
AT liyanyan dl3nbutylphthalidepromotesangiogenesisinanoptimizedmodeloftransientischemicattackinc57bl6mice
AT yuhaihan dl3nbutylphthalidepromotesangiogenesisinanoptimizedmodeloftransientischemicattackinc57bl6mice
AT ligaigai dl3nbutylphthalidepromotesangiogenesisinanoptimizedmodeloftransientischemicattackinc57bl6mice
AT baishuang dl3nbutylphthalidepromotesangiogenesisinanoptimizedmodeloftransientischemicattackinc57bl6mice
AT chenshiling dl3nbutylphthalidepromotesangiogenesisinanoptimizedmodeloftransientischemicattackinc57bl6mice
AT zhangping dl3nbutylphthalidepromotesangiogenesisinanoptimizedmodeloftransientischemicattackinc57bl6mice
AT tangzhouping dl3nbutylphthalidepromotesangiogenesisinanoptimizedmodeloftransientischemicattackinc57bl6mice